# Ensysce Biosciences, Inc. (ENSC)

- Sector: Healthcare · Industry: Biotechnology
- SEC CIK: 0001716947 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001716947))
- Full page: https://inspectstocks.com/stocks/ensc
- Data as of: price 2026-09-28; newest filing used 2026-08-13; latest fiscal period ended 2026-06-30

## Grade

**D-** on the balance-sheet rubric used for lenders, 1 of 4 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -$12.6M |  |
| Earnings growing overall | passed | -$12.6M | -$19.8M |
| Earnings growing recently | failed | -$12.6M | -$10.2M |
| Earns well on its assets | failed | -426.9% |  |
| Book value per share growing | not answerable | $1.26 | -$20.64 |

Business quality (the + / − mark): 1 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -280.5% |  |
| Healthy profit margin | failed | -280.5% |  |
| Strong operating margin | failed | -281.3% |  |
| Good return on equity | failed | -392.8% |  |
| Debt under control | passed | 0.07 |  |
| Turns sales into cash | failed | -176.2% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $4.5M |
| Net income, trailing twelve months | -$12.6M |
| Free cash flow, trailing twelve months | -$7.9M |
| Net margin | -280.5% |
| Operating margin | -281.3% |
| Return on equity | -392.8% |
| Debt to equity | 0.07 |
| Diluted EPS, trailing twelve months | -$2.57 |
| Share price | $0.40 |
| Market value | $7.8M |
| Price / sales | 1.7x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/ensc)
- [Financial statements](https://inspectstocks.com/stocks/ensc/financials)
- [Competitors](https://inspectstocks.com/stocks/ensc/peers)
- [Earnings](https://inspectstocks.com/stocks/ensc/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.